Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EUROPE

Denmark

France

Germany

Hungary

Ireland

Italy

Netherlands

Poland

Portugal

Romania

Spain

Sweden

United Kingdom

EMEA (REGIONAL)

Egypt

South Africa

Tunisia

Turkey

Ukraine

ASIA PACIFIC

Asia Pacific (Regional)

China

India

Indonesia

Japan

Korea

Malaysia

Philippines

Tulaven box and bottle
Tulaven box
Tulaven bottle
Tulaven box and bottle
Tulaven box
Tulaven bottle

Tulaven

Tulathromycin injectable in CLAS vial

Available in:

  • 50 mL
  • 100 mL

Target species:

  • cattle icon Cattle
  • sheep icon Sheep
  • pig icon Swine

Product information

How to use

Solution of subcutaneous use in cattle and intramuscular use in sheep and pigs.
One single injection: 1 mL/40kg
Withdrawal period (meat and offal): 22 days (cattle), 16 days (sheep), 13 days (pigs)

Legal Category: IE POM

Neonatal calf and cow. Reproduction.

Why choose
Tulaven?

Broad Spectrum

Highly effective on most common bacteria causing BRD including Mycoplasma bovis

Long duration of action

Persists above the MIC in tissues, enabling: 15 days of coverage for P. multocida; 15 days for H. somni and 9 days for M. haemolytica1,2

Low dose volume

Cattle: 1 ml/40 kg bodyweight

Sheep: 1 ml/40 kg bodyweight

Pigs: 1 ml/ 40kg bodyweight

Ovine foot rot

Licenced for the treatment of the early stages of infectious pododermatitis (foot rot) in sheep

Pink eye

Licenced for the treatment of this  common infectious ocular disease of cattle, caused by Moraxella bovis

Hi-tech CLAS vial

Shock resistant3, eco-friendly4, easier handling vials

References

1.Nowakowski, M.A., Inskeep, P.B., Risk, J.E., Skogerboe, T.L., Benchaoui, H.A., Meinert, T.R., Sherington, J., Sunderland, S.J., 2004. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilid ...

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.